2.10
生物制药研究是一个重要领域,旨在利用各种跨学科知识来改进药物输送方法和优化治疗方法。在研究方法中,对照研究和非对照研究之间的选择会显著影响研究的可靠性和准确性。
非对照研究通常用于初步探索,缺乏对照组,因此容易受到偏见和外界影响。相比之下,对照研究采用各种技术,包括安慰剂、历史、交叉或标准治疗对照,…
生物制药学研究旨在利用跨学科知识来研究药物递送和改进治疗方法。
非对照研究常用于初步探索,由于缺乏对照组,可能导致偏倚和外部因素的干扰。
相反,对照研究采用对照组,并结合安慰剂、历史对照、交叉对照或标准治疗对照等技术以减少偏倚。
为了进一步减少偏倚,设盲可使受试者或研究者不知道所分配的治疗方案。这包括单盲、双盲和双模拟研究。
混杂因素由影响研究结果的外部变量引起,可通过合理的研究设计、方法学和统计分析加以控制,从而有助于验证研究的可靠性。
内部效度涉及研究实施的质量,而外部效度则衡量研究结果对其他人群的适用性。
在临床研究中,风险计算用于估计暴露与结局之间的关联。其涵盖的指标包括绝对风险和相对风险、绝对风险降低量和相对风险降低量、治疗所需人数,以及风险比和比值比。
View the full transcript and gain access to JoVE Core videos
Q1: What is the main difference between controlled and non-controlled biopharmaceutical studies?
Non-controlled studies lack a control group, making them susceptible to biases and external influences, though useful for initial exploration. Controlled studies employ control groups and techniques such as placebo, historical, crossover, or standard treatment controls to reduce bias and validate findings more rigorously.
Q2: How does blinding reduce bias in biopharmaceutical research?
Blinding keeps participants or investigators unaware of assigned treatments, preventing biased observations. Single-blind designs hide treatment from participants only, double-blind designs hide it from both participants and investigators, and double-dummy designs use placebos for one treatment while administering the active form of another to maintain blinding across different treatment types.
Q3: What role do confounding variables play in study validity?
Confounding variables are external factors that can affect study outcomes and compromise reliability. Proper study design, meticulous methodology, and statistical analysis mitigate confounding effects. Addressing confounding is essential for establishing internal validity, which assesses the quality of study execution and the experimental design's impact on results.
Q4: How do internal and external validity differ in biopharmaceutical studies?
Internal validity assesses the quality of study execution and how well the experimental design controls for bias and confounding. External validity gauges whether study findings apply to broader populations and real-world scenarios, ensuring research outcomes hold relevance beyond the immediate study group.
Q5: What measures are used to calculate risk in clinical biopharmaceutical studies?
Risk calculation estimates the exposure-outcome association using measures like absolute and relative risks, absolute and relative risk reduction, treatment numbers, and hazard and odds ratios. These calculations quantify risks associated with specific interventions, providing insights into treatment benefits and drawbacks to guide clinical decisions.
Q6: Why is statistical analysis important for addressing confounding in biopharmaceutical research?
Statistical analysis helps validate study findings by identifying and controlling for confounding variables that could distort results. Advanced statistical methods work alongside proper study design and methodology to isolate the true effect of treatments, strengthening the reliability of conclusions drawn from biopharmaceutical studies.
Q7: What interdisciplinary knowledge supports biopharmaceutical study design?
Biopharmaceutical studies integrate diverse fields to enhance drug delivery methods and refine therapeutic approaches. This interdisciplinary foundation informs the selection of appropriate study designs, control mechanisms, blinding techniques, and statistical methods needed to produce reliable, valid research that advances pharmaceutical science and patient care.